baicalin has been researched along with Allergic Encephalomyelitis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ciric, B; Gran, B; Li, X; Ma, CG; Rostami, A; Zhang, GX; Zhang, Y | 1 |
Huang, R; Jin, SJ; Xu, J; Yang, YJ; Zhang, JF | 1 |
Ding, X; Ji, X; Song, C; Yi, L; Zeng, Y; Zhu, K | 1 |
3 other study(ies) available for baicalin and Allergic Encephalomyelitis
Article | Year |
---|---|
Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Flavonoids; Inflammation Mediators; Lymphocyte Activation; Mice; Multiple Sclerosis; NF-kappa B; Signal Transduction; STAT Transcription Factors; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; T-Lymphocyte Subsets; Th1 Cells; Th17 Cells | 2015 |
[Effects of baicalin on apoptosis in rats with autoimmune encephalomyelitis].
Topics: Animals; Apoptosis; Dexamethasone; Encephalomyelitis, Autoimmune, Experimental; Female; Flavonoids; In Situ Nick-End Labeling; Rats; Rats, Wistar | 2011 |
Baicalin reduces the severity of experimental autoimmune encephalomyelitis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Encephalomyelitis, Autoimmune, Experimental; Female; Flavonoids; Interferon-gamma; Interleukin-4; Mice; Severity of Illness Index; T-Lymphocytes | 2007 |